يعرض 1 - 10 نتائج من 185 نتيجة بحث عن '"Muñoz-Couselo, Eva"', وقت الاستعلام: 1.61s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Remon J Paris-Saclay University, Department of Cancer Medicine, Gustave Roussy, Villejuif. Auclin E Department of Cancer Medicine, Hôpital Européen Georges-Pompidou, Paris, France. Zubiri L Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, USA. Schneider S Department Pneumology, Hôpital de Bayonne, Bayonne, France. Rodriguez-Abreu D Medical Oncology Department, Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain. Minatta N Department of Oncology Hospital Italiano Buenos Aires, Buenos Aires, Argentina. Muñoz-Couselo E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: ESMO Open;9(5); https://doi.org/10.1016/j.esmoop.2024.103004Test; Remon J, Auclin E, Zubiri L, Schneider S, Rodriguez-Abreu D, Minatta N, et al. Immune checkpoint blockers in solid organ transplant recipients and cancer: the INNOVATED cohort. ESMO Open. 2024 Apr 22;9(5):103004.; https://hdl.handle.net/11351/11393Test

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Cortes J Oncology Department, International Breast Cancer Center (BCC), Pangaea Oncology, Quirónsalud, Barcelona, Spain. Department of Medicine, Faculty of Biomedical and Health Sciences, European University of Madrid, Madrid, Spain. Winer EP Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. Lipatov O Department of Oncology, Republican Clinical Oncology Dispensary of the Ministry of Public Health of Bashkortostan Republic, Ufa, Russia. Im SA Department of Internal Medicine, Seoul National University Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea. Gonçalves A Aix Marseille University, CNRS, INSERM, Department of Medical Oncology, Institut Paoli-Calmettes, CRCM, Marseille, France. Muñoz-Couselo E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: The Journal of Pathology: Clinical Research;10(3); https://doi.org/10.1002/2056-4538.12371Test; Cortes J, Winer EP, Lipatov O, Im SA, Gonçalves A, Muñoz-Couselo E, et al. Contribution of tumour and immune cells to PD-L1 expression as a predictive biomarker in metastatic triple-negative breast cancer: exploratory analysis from KEYNOTE-119. J Pathol Clin Res. 2024 May;10(3):e12371.; https://hdl.handle.net/11351/11362Test

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, González-Cruz C, García-Patos V, Ferrándiz-Pulido C Servei de Dermatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Muñoz-Couselo E, Ortiz-Velez C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona Spain. Vall d’Hebron Institute of Oncology (VHIO), Biblioteca, Spain. Ferrer B Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: JAAD Case Reports;46; https://doi.org/10.1016/j.jdcr.2024.02.011Test; González-Cruz C, Muñoz-Couselo E, Ortiz-Velez C, Ferrer Fàbrega B, García-Patos Briones V, Ferrándiz-Pulido C. Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy. JAAD Case Reports. 2024 Mar 1;46:67–9.; https://hdl.handle.net/11351/11307Test

  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Spreafico A Department of Medicine, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Canada. Muñoz Couselo E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Irmisch A Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland. Bessa J Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland. Au-Yeung G Department of Medical Oncology, Peter MacCallum Cancer Center and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. Bechter O Department of General Medical Oncology, Universitair Ziekenhuis (UZ), Leuven, Belgium, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Frontiers in Oncology;14; https://doi.org/10.3389/fonc.2024.1346502Test; Spreafico A, Muñoz Couselo E, Irmisch A, Bessa J, Au-Yeung G, Bechter O, et al. Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposure. Front Oncol. 2024 Mar 21;14:1346502.; https://hdl.handle.net/11351/11306Test

  5. 5
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Weiss SA, Sznol M Yale University School of Medicine, New Haven, Connecticut. Shaheen M University of Arizona Cancer Center, Tucson, Arizona. Berciano-Guerrero MÁ Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigacion Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Málaga, Spain. Muñoz Couselo E Vall d’Hebron Hospital Universitari, Barcelona, Spain. Rodríguez-Abreu D Universidad de Las Palmas de Gran Canaria, Las Palmas, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical Cancer Research;30(1); https://doi.org/10.1158/1078-0432.CCR-23-0475Test; Weiss SA, Sznol M, Shaheen M, Berciano-Guerrero MÁ, Muñoz Couselo E, Rodríguez-Abreu D, et al. A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy. Clin Cancer Res. 2024 Jan 1;30(1):74–81.; https://hdl.handle.net/11351/10921Test

  6. 6
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Mandalà M Unit of Medical Oncology, University of Perugia, Perugia, Italy. Lorigan P, Serra P The University of Manchester, Oxford Rd, Manchester M13 9PL, UK. Sergi MC Medical Oncology Unit, Azienda Ospedaliero Universitaria Policlinico di Bari, Bari, Italy. Benannoune N Gustave Roussy Cancer Campus, Villejuif, France. Vitale MG Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione "G. Pascale" Napoli, Naples, Italy. Munoz Couselo E Servei d’Oncologia Mèdica, Vall d′Hebron Hospital, Barcelona, Spain. Vall d′Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: European Journal of Cancer;199; https://doi.org/10.1016/j.ejca.2024.113542Test; Mandalà M, Lorigan P, Sergi MC, Benannoune N, Serra P, Vitale MG, et al. Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study. Eur J Cancer. 2024 Mar;199:113542.; https://hdl.handle.net/11351/11058Test

  7. 7
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Clavero-Rovira L, Bodet D Servei de Dermatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Gómez-Tomás Á, Bassas-Freixas P, García-Patos V, Ferrándiz-Pulido C Servei de Dermatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Ferrer B, Hernández-Losa J Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Muñoz-Couselo E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Pérez-Benavente A Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Unitat de Ginecologia Oncològica i Patologia del Tracte Genital, Servei d’Obstetrícia i Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cancers;16(1); https://doi.org/10.3390/cancers16010227Test; Clavero-Rovira L, Gómez-Tomás Á, Bassas-Freixas P, Bodet D, Ferrer B, Hernández-Losa J, et al. Mucosal Melanoma Clinical Management and Prognostic Implications: A Retrospective Cohort Study. Cancers. 2024 Jan 3;16(1):227.; https://hdl.handle.net/11351/11013Test; 001139195500001

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية

    المساهمون: Weber, Jeffrey S, Schadendorf, Dirk, Del Vecchio, Michele, Larkin, Jame, Atkinson, Victoria, Schenker, Michael, Pigozzo, Jacopo, Gogas, Helen, Dalle, Stéphane, Meyer, Nicola, Ascierto, Paolo A, Sandhu, Shahneen, Eigentler, Thoma, Gutzmer, Ralf, Hassel, Jessica C, Robert, Caroline, Carlino, Matteo S, Di Giacomo, Anna Maria, Butler, Marcus O, Muñoz-Couselo, Eva, Brown, Michael P, Rutkowski, Piotr, Haydon, Andrew, Grob, Jean-Jacque, Schachter, Jacob, Queirolo, Paola, de la Cruz-Merino, Lui, van der Westhuizen, Andre, Menzies, Alexander M, Re, Sandra, Bas, Tuba, de Pril, Veerle, Braverman, Julia, Tenney, Daniel J, Tang, Hao, Long, Georgina V

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36162037; info:eu-repo/semantics/altIdentifier/wos/WOS:000928326300014; volume:41; issue:3; firstpage:517; lastpage:527; numberofpages:11; journal:JOURNAL OF CLINICAL ONCOLOGY; https://hdl.handle.net/11365/1232438Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85143235746; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870220Test/